Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy

Toshihide Hinoi,Yasuyuki Tomohiro,Shinji Kajiwara,Syusuke Matsuo,Yukihiro Fujimoto,Shu Yamamoto,Takeshi Shichijo,Tetuya Ono

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy

2008

Toshihide Hinoi
Yasuyuki Tomohiro
Shinji Kajiwara
Syusuke Matsuo
Yukihiro Fujimoto
Shu Yamamoto
Takeshi Shichijo
Tetuya Ono

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy

Keywords:

Essential hypertension
Insulin resistance
Left ventricular hypertrophy
Coronary circulation
Angiotensin II
Microcirculation
Endocrinology
Internal medicine
Telmisartan
Medicine
Cardiology
Coronary flow reserve
Nifedipine
Blood pressure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations